|
Market Closed -
NSE India S.E.
07:12:09 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 2,907.90 INR | +1.38% |
|
+1.20% | +68.87% |
| 09-01 | Indian shares open lower as widening Iran conflict sends oil higher | RE |
| 08-14 | Gland Pharma Names Dr. Reddy's Executive as CEO | MT |
| Market Cap | 480B 5.07B 4.37B 4.1B 3.75B 7B 7.05B 48.47B 18.88B 245B 19.06B 18.64B 790B | P/E 2027 * |
36.5x | P/E 2028 * | 30x |
|---|---|---|---|---|---|
| Enterprise Value | 442B 4.68B 4.03B 3.78B 3.46B 6.45B 6.5B 44.69B 17.4B 226B 17.57B 17.19B 728B | EV / Sales 2027 * |
5.9x | EV / Sales 2028 * | 5.04x |
| Free-Float |
48.23% | Yield 2027 * |
0.7% | Yield 2028 * | 0.77% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLAND | Delayed | |
Bombay S.E.
| GLAND | Delayed |
Last Transcript : Gland Pharma Limited
| 1 day | +1.38% | ||
| 1 week | +1.20% | ||
| Current month | +0.77% | ||
| 1 month | +12.74% | ||
| 3 months | +30.26% | ||
| 6 months | +70.21% | ||
| Current year | +68.87% |
| 1 week | 2,803 | 2,948 | |
| 1 month | 2,531.1 | 3,039.8 | |
| Current year | 1,573.6 | 3,039.8 | |
| 1 year | 1,573.6 | 3,039.8 | |
| 3 years | 1,277.8 | 3,039.8 | |
| 5 years | 861 | 4,179.65 | |
| 10 years | 861 | 4,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2019-09-29 | |
| Chief Operating Officer | - | 2026-04-05 | |
Jitendra Gangwal
CTO | Chief Tech/Sci/R&D Officer | - | 2026-02-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Srinivas Sadu
CHM | Chairman | 57 | 2024-06-09 |
| Director/Board Member | 71 | 2018-02-06 | |
Naina Lal Kidwai
BRD | Director/Board Member | 69 | 2021-05-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/26/25 | Buy | 2,800 | 0.0017% | |||
| 6/28/24 | Sell | 1,950 | 0.0012% | |||
| 6/28/24 | Sell | 1,400 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.38% | +1.20% | +54.94% | +70.15% | 5.01B | ||
| -0.17% | -1.53% | +56.96% | +107.47% | 1,034B | ||
| +1.02% | +4.63% | +56.22% | +73.06% | 663B | ||
| -0.29% | +1.15% | +23.25% | +78.72% | 462B | ||
| +2.09% | -2.06% | +32.28% | +38.37% | 344B | ||
| 0.00% | +5.36% | +27.40% | +47.50% | 307B | ||
| +1.42% | +0.26% | -0.52% | +13.62% | 251B | ||
| +0.17% | +1.49% | +56.25% | +74.61% | 239B | ||
| -0.03% | +2.13% | -17.30% | -53.99% | 207B | ||
| +0.63% | +1.30% | +33.45% | +100.63% | 186B | ||
| Average | +0.76% | -0.75% | +32.29% | +55.01% | 369.84B | |
| Weighted average by Cap. | +0.57% | -0.84% | +38.58% | +68.38% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 74.93B 793M 682M 640M 586M 1.09B 1.1B 7.57B 2.95B 38.29B 2.98B 2.91B 123B | 85.84B 908M 781M 733M 671M 1.25B 1.26B 8.67B 3.38B 43.87B 3.41B 3.34B 141B |
| Net income | 13.12B 139M 119M 112M 103M 191M 193M 1.33B 516M 6.7B 521M 510M 21.59B | 15.95B 169M 145M 136M 125M 233M 234M 1.61B 628M 8.15B 634M 620M 26.25B |
| Net Debt | -37.45B -396M -341M -320M -293M -546M -551M -3.78B -1.47B -19.14B -1.49B -1.46B -61.64B | -47.28B -500M -430M -404M -369M -690M -695M -4.78B -1.86B -24.16B -1.88B -1.84B -77.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | ₹2,907.90 | +1.38% | 189,288 |
| 26-09-02 | ₹2,868.40 | -0.23% | 556,481 |
| 26-09-01 | ₹2,875.00 | -0.37% | 257,559 |
| 26-08-31 | ₹2,885.80 | -0.08% | 370,779 |
| 26-08-28 | ₹2,888.00 | +0.50% | 165,191 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAND Stock
Select your edition
All financial news and data tailored to specific country editions

















